Results 211 to 220 of about 9,660 (240)
Tacrolimus and Hyaluronate Therapy Enhance Tear Film Stability in Canine Evaporative Dry Eye Disease
Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.ABSTRACT Objective Evaluate the efficacy of a therapeutic approach combining tacrolimus and hyaluronate‐based lubricant for the management of evaporative dry eye disease (EDED) in dogs, compared to hyaluronate monotherapy. Procedures Fifty‐four client‐owned dogs with EDED were randomly assigned to three groups (n = 18 each): Group 1 received 0.03 ...
Lionel Sebbag +2 more
wiley +1 more source
Analysis of Cytokine and Chemokine Level in Tear Film in Keratoconus Patients before and after Corneal Cross-Linking (CXL) Treatment. [PDF]
Int J Mol SciKrok M +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Corneal Collagen Cross-linking
American Journal of Ophthalmology, 2012Corneal collagen cross-linking has recently emerged as a novel approach for management of ectasia. This article reviews the literature published in the past 3 years about the expanding spectrum of cross-linking as a therapeutic modality and its complications.Recent studies have confirmed the beneficial effects of cross-linking in stabilization and to a
Kunal, Suri +2 more
+6 more sources
Progress in Retinal and Eye Research
First introduced over 20 years ago as a treatment for progressive keratoconus, the original "Dresden" corneal cross-linking (CXL) protocol involved riboflavin saturation of the stroma, followed by 30 min of 3 mW/cm2-intensity ultraviolet-A (UV-A) irradiation.
Farhad Hafezi +10 more
+6 more sources
First introduced over 20 years ago as a treatment for progressive keratoconus, the original "Dresden" corneal cross-linking (CXL) protocol involved riboflavin saturation of the stroma, followed by 30 min of 3 mW/cm2-intensity ultraviolet-A (UV-A) irradiation.
Farhad Hafezi +10 more
+6 more sources
Survey of Ophthalmology, 2015
Since its inception in the late 1990s, corneal cross-linking has grown from an interesting concept to a primary treatment for corneal ectatic disease worldwide. Using a combination of ultraviolet-A light and a chromophore (vitamin B2, riboflavin), the cornea can be stiffened, usually with a single application, and progressive thinning diseases such as ...
J. Bradley Randleman +2 more
openaire +2 more sources
Since its inception in the late 1990s, corneal cross-linking has grown from an interesting concept to a primary treatment for corneal ectatic disease worldwide. Using a combination of ultraviolet-A light and a chromophore (vitamin B2, riboflavin), the cornea can be stiffened, usually with a single application, and progressive thinning diseases such as ...
J. Bradley Randleman +2 more
openaire +2 more sources
2021
Corneal cross-linking was first introduced in 2003 as a novel approach to halt progression of corneal ectasia. Adopted early, and widely used abroad, the FDA approved a drug device combination product for corneal cross-linking in the United States in 2016.
Stephen Tse +2 more
openaire +1 more source
Corneal cross-linking was first introduced in 2003 as a novel approach to halt progression of corneal ectasia. Adopted early, and widely used abroad, the FDA approved a drug device combination product for corneal cross-linking in the United States in 2016.
Stephen Tse +2 more
openaire +1 more source
Expert Review of Ophthalmology, 2014
Corneal collagen cross-linking (CXL) entails the use of ultraviolet light with a cross-linking agent to form cross bridges in the corneal collagen fibers with subsequent strengthening of the corneal stroma. CXL was first reported on humans in 2003 for patients with keratoconus.
Majed Alkharashi +2 more
openaire +1 more source
Corneal collagen cross-linking (CXL) entails the use of ultraviolet light with a cross-linking agent to form cross bridges in the corneal collagen fibers with subsequent strengthening of the corneal stroma. CXL was first reported on humans in 2003 for patients with keratoconus.
Majed Alkharashi +2 more
openaire +1 more source
Expanding indications for corneal cross-linking
Current Opinion in Ophthalmology, 2023Purpose of review The aim of this study was to summarize the recent developments in corneal cross-linking (CXL) and its indications, including corneal ectasias, refractive surgery and infectious keratitis. Recent findings Advances in CXL technology, such as the use of higher ...
Farhad, Hafezi +2 more
openaire +2 more sources
Customized Corneal Cross-Linking
2018Personalized accelerated crosslinking nomograms for the management of corneal ectasia were conceived after comparative analysis of demarcation lines and cell viability observed after customized accelerated epithelium-off crosslinking CXL treatments by spectral domain corneal OCT and scanning laser in vivo confocal microscopy matching all the clinical ...
Mazzotta C., Rechichi M., Ferrise M.
openaire +3 more sources
Corneal Infiltrates After Corneal Collagen Cross-Linking
Journal of Refractive Surgery, 2010Purpose: To present a case of advancing keratoconus treated with corneal collagen cross-linking (CXL) with ultraviolet A (UVA) light and riboflavin complicated with sterile infiltrates. Methods: The patient’s cornea was de-epithelialized and CXL was performed with ...
George F, Mangioris +5 more
openaire +2 more sources